Ngo et al in the Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds.) Birkhauser Boston 1994, pp. 491-495.* |
Dorland's Illustrated Medical Dictionary 26th Edition W.B. Saunders Co Philadelphia 1981 pp. 281-282, 1071 Only.* |
Callas et al. Thrombosy and Haemostasis 74:473-481 (1995).* |
Gitel at al. J. Lab Clin med. 1979, 94(3) pp. 481-488.* |
I. Lindahl Current Opinion in Lipidology 5:434-439 (1994).* |
Bjorklid et al., “The Protein Component of Human Brain Thromboplastin” Biochemical and Biophysical Research Communications 55 (3):969-976 (1973). |
Esnouf, “Extrinsic Activation of Prothrombin” Human Blood Coagulation, Haemostasis and Thrombosis pps. 55-65 (1976). |
Tanaka et al., “Purification of Glycosylated Apoprotein of Tissue Factor from Human Brain and Inhibition of Its Procoagulant Activity by a Specific Antibody” Chemical Abstracts (Abstract No. 49211z) 104:366 (1986). |
Van Den Besselaar et al., “Tissue Factor-Induced Coagulation Can Be Inhibited by Aprotinin (Trasylol)” Thrombosis and Haemostasis 69:298-299 (1993). |
Zacharski et al. 20˜, “Reduced Tissue Factor (Thromboplastin) Activity in von Willebrand's Disease” American J. of Medicine 57:102-107 (1974). |
Bach et al. Abstracts of the 59th Scientific Sessions (oral presentation, Annual Convention of the American Heart Assn.) (Nov. 19, 1986). |
Bach et al., “Factor VII Binding to Tissue Factor in Reconstituted Phospholipid Vesicles: Induction of Cooperativity by Phosphatidylserine” Biochemistry 25:4007-4020 (1986). |
Bach et al., “Purification and Characterization of Bovine Tissue Factor” Journal of Biological Chemistry 256 (16):8324-8331 (1981). |
Baldus et al., “Successful recanalization of experimentally occluded coronary arteries in anesthetised dogs and recombinant single-chain tissue-type plasminogen activator (sct-PA)” Fibrinolysis 1(1):23-28 (1987). |
Beck et al. Hematology, MIT Press pps. 381-382 & 436-437 (1981). |
Bjorklid et al., “Purification and Some Properties of the Protein Component of Tissue Thromboplastin from Human Brain” Biochemical Journal 165(1):89-96 (1977). |
Blakeslee et al., “Scientists find Long-Sought Key to How Blood Clots” New York Times (Jul. 7, 1987). |
Bom et al., “Application of Factor VII-Sepharose Affinity Chromatography in the Purification of Human Tissue Factor Apoprotein” Thrombosis Research 42:635-643 (1986). |
Brommer et al., “Survival of fibrinogen degradation products in the circulation after thrombolyic therapy for acute myocardial infarction” Fibrolysis 1(3):149-153 (1987). |
Broze et al., “Isolation of the Tissue Factor Inhibitor Produced by HepG2 Hepatoma Cells” Proc. Natl. Acad. Sci. USA 84:1886-1890 (Apr. 1987). |
Broze, Jr. et al., “The Lipoprotein-Associated Coagulation Inhibitor That Inhibits the Factor VII-Tissue Factor Complex Also Inhibits Factor Xa: Insight Into Its Possible Mechanism of Action” Blood 71(2):335-343 (Feb. 1988). |
Broze, Jr., et al., “Purification of Human Brain Tissue Factor” Journal of Biological Chemistry 260(20):10917-10920 (1985). |
Carlsen et al., “Intravenous Injections of Tissue Thromboplastin and Phospholipase C in Sheep” Thrombosis Haemostasis 48(3):315-319 (1982). |
Carson et al., “An inhibitory monoclonal antibody against human tissue factor” Blood 70(2):490-493 (1987). |
Carson et al., “Lipid activation of coagulation factor III apoprotein (tissue factor)—reconstitution of the protein-membrane complex” Chemical Abstracts 94(244):13337f (1981). |
Carson et al., “Monoclonal Antibodies Aginst Bovine Tissue Factor, Which Block Interaction with Factor VIIa” Blood 66(1):152-156 (1985). |
Carson et al., “Plasma High Density Lipoproteins Inhibit the Activation of Coagualtion Factor X by Factor VIIa and Tissue Factor” FEBS Letters 132(1):37-40 (1981). |
Carson et al., “Tissue Factor Gene Localized to Human Chromosome 1 (1pter-1p21)” Science 229:991-993 (1985). |
Carson, S.D., “Tissue Factor-Initiated Blood Coagulation” Progress in Clinical Pathology, Stefanini et al., Grune & Stratton vol. 9:1-14 (1984). |
Collen et al., “Thrombolytic Therapy” Annu. Rev. Med. 39:405-423 (Apr. 1988). |
Dennis et al., “Kunitz Domain Inhibitors of Tissue Factor-Factor VIIa; I. Potent Inhibitors Selected from Libraries by Phage Display” Journal of Biological Chemistry 269(35):22129-22136 (1994). |
Edgington et al., “Molecular Cloning of Human Tissue Factor cDNA” Thrombosis and Haemostasis (Abstract No. 941) 58(1):258 (Jan. 1987). |
Ewan et al., “Production and Characterization of a Monoclonal Antibody (A1-3) That Binds Selectively to Activated Monocytes and Inhibits Monocyte Procoagulant Activity” J. Immunol. 136(7):2408-2415 (1986). |
Falk, “Plaque Rupture with Severe Pre-existing Stenosis Precipitating Coronary Thrombosis” Br. Heart J. 50:127-134 (1983). |
Fisher, K.L. et al., “Cloning and Expression of Human Tissue Factor cDNA” Thrombosis Research 48(1):89-99 (1987). |
Freyssinet et al., “Coextraction of Thrmobomodulin and Tissue Factor from Huam Placenta: Effects of Concanavalin A and Phospholid Environment on Activity” Thrombosis and Haemostasis 55(1):112-118 (1986). |
Giercksky et al., “The Effect of Intravenous Injection of Purified Human Tissue Thromboplastin in Rats” Scand. J. Haematol. 16(4):300-310 (Apr. 1976). |
Gollub et al., “Thromboplastinase-an Experimental Anti-thrombotic” Thromb. Diath. Haemorh. 7:470-479 (1962). |
Gonmori et al., “The Role of Tissue Thromboplastin in the Development of DIC Accompanying Neoplastic Diseases” Biblio. Haematol. 49:23-39 (1983). |
Guha et al., “Affinity purification of human tissue factor: Interaction of factor VII and tissue factor in detergent micelles” Proc. Natl. Acad. Sci. USA 83:299-302 (1986). |
Harker, “Role of Platelets and Thrombosis in Mechanisms of Acute Occlusion and Restenosis After Angioplasty” The American Journal of Cardiology 60:20B-28B (Jul. 1987). |
Haskel et al., “Prevention of Arterial Reocclusion After Thrombolysis With Recombinant Lipoprotein-Associated Coagulation Inhibitor” Circulation 84:821-827 (1991). |
Haskel et al., “Prevention of Reoccluding Platelet-Rich Thrombi in Canine Femoral Arteries With a Novel Peptide Antagonist of Platelet Glycoprotein IIb/IIIa Receptors” Circulation 80(6):1775-1782 (1989). |
Jang et al., “Antithrombotic Effect of a Monoclonal Antibody Against Tissue Factor in a Rabbit Model of Platelet-Mediated Arterial Thrombosis” Arteriosclerosis and Thrombosis 12(8):948-954 (Aug. 1992). |
Johns et al., “Prevention of Coronary Artery Reocclusion and Reduction in Late Coronary Artery Stenosis After Thrombolytic Therapy in Patients With Acute Myocardial Infarction” Circulation 78(3):546-556 (1988). |
Kelley et al., “Analysis of the Factor VIIa Binding Site on Human Tissue Factor: Effects of Tissue Factor Mutations on the Kinetics and Thermodynamics of Binding” Biochemistry 34:10383-10392 (1995). |
Kittler et al., “Identification of a cDNA Clone for Bovine Tissue Factor” 76th Ann. Mtg. of the American Society of Biol. Chemists. Wash., D.C., Fed. Proc. (Abstract 927) 45(6):1639 (Jun. 1986). |
Konigsberg et al., “Molecular Cloning of the cDNA for Human Tissue Factor” Cell 52:639-640 (1988). |
Kurosawa et al., “Urinary Procoagulant Behaves as Tissue Factor by Promoting Factor VIIa-Catalyzed Activation of Factor X” Thrombosis Research 33:595-606 (1984). |
Lewis et al., “Effects of intravaneous tissue thomboplastin in dogs: Development of an anticogulant” J. Lab. Clin. Med. 60(2):261-273 (1962). |
Light, A., “Protein Solubility, Protein Modification and Protein Folding” Biotechniques 3(4):298-306 (1985). |
Lyberg, “Clinical Significance of Increased Thromboplastin Activity on the Monocyte Surface—A Brief Review” Haemostasis 14(5):430-439 (1984). |
Morrissey et al., “Differential Expression and Subcellular Localization of Tissue Factor in Constitutive Versus an Inducible Cell Type” Thrombosis and Haemostasis (Abstract No. 940) 58(1):258 (1987). |
Morrissey et al., “Molecular Cloning of the cDNA for Human Tissue Factor” Fed. of Amer. Society for Exp. Biol. (71st Annual Mtg. Mar. 29, 1987-Apr. 2, 1987, Abstract #2338) 46(3):716 (Mar. 1, 1987). |
Morrissey et al., “Molecular Cloning of the cDNA for Tissue Factor, the Cellular Receptor for the Initiation of the Coagulation Protease Cascade” Cell 50(1):129-135 (1987). |
Morrissey et al., “Properties of Tissue Factor Purified from Human Brain and Placenta” Abstracts of the 59th Scientific Sessions (Annual Convention of the American Heart Assn., Abstract #1632) (Nov. 1986). |
Morrissey et al., “Resolution of Monomeric and Heterodimeric Forms of Tissue Factor, the High Affinity Cellular Receptor for Factor VII” Thrombosis Research 50:481-493 (1988). |
Nemerson, “Characteristics and Lipid Requirements of Coagulant Proteins Extracted from Lung and Brain: the Specifity of the Protein Component of Tissue Factor” J. Clin. Invest. 48:322-330 (1969). |
Nemerson, “The Phospholid Requirement of Tissue Factor in Blood Coagulation” J. Clin. Invest. 47:72-80 (1968). |
Nemerson et al., “The role of lipids in the tissue factor pathway of blood coagulation” Chemical Abstracts 84(133467P) :314 (1976). |
Nemerson et al., “Tissue Factor Revisited” Progress in Hemostasis and Thrombosis 6:237-260 (1982). |
Niemetz, J., “Coagulant Activity of Leukocytes” J. Clin. Invest. 51:307-313 (1972). |
Osterud et al., “Activation pathways of the coagulation system in normal haemostasis” Scand. J. Haematol. 32:337-345 (1984). |
Osterud, B., “the Interaction of Human blood Coagulation Factor VII and Tissue Factor: The Effect of Anti Factor VII, anti Tissue Factor an Diisopropylfluorophospate” Biochem.& Biophys. Res. Comm. 88(1):59-67 (1979). |
Pawashe et al., “A Monoclonal Antibody Against Rabbit Tissue Factor Inhibits Thrombus Formation in Stenotic Injured Rabbit Carotid Arteries” Circ. Res. 74:56-63 (1994). |
Pepe et al., “Functional site on Human Tissue Factor” FASEB J. (Abstract No. 552) 2(4):A391 (May 5, 1988). |
Pitlick et al., “Binding of the Protein Component of Tissue Factor to Phospholids” Biochemistry 9(26):5105-5113 (1970). |
Pitlick et al., “Concanavalin A Inhibits Tissue Factor Coagulant Activity” J. Clin. Invest. 55:175-179 (1975). |
Rao et al., “Affinity Purification of Human Brain Tissue Factor Utilizing Factor VII Bound Immobilized Anti-factor VII 1,2” Analytical Biochemistry 165:365-70 (1987). |
Ross, Russell, “The Pathogenesis of Atherosclerosis—An Update” N. England Jour. of Medicine 314(8):488-500 (1986). |
Scarpati et al., “Human Tissue Factor: cDNA Cloning, Primary Structure, and Chromosome Localization” (Paper 1846, Amer. Society for Exp. Biol. 78th Annual Mtg. Jun. 7, 1987-Jun. 11, 1987) 46(6):2242 (abs) (May 1, 1987). |
Scarpati et al., “Human Tissue Factor: cDNA Sequence and Chromosome Localization of the Gene” Biochemistry 26(17):5234-5238 (1987). |
Schneider, “The Active Principle of Placental Toxin: Thromboplastin; Its Inactivator in Blood: Antithromboplastin” Am. J. Physiol. 149:123-127 (1946). |
Sojar et al., “A Chemical Method for the Deglycosylation of Proteins” Archives of Biochemistry & Biophysics 259(1):52-57 (1987). |
Spicer et al., “Isolation of cDNA clones coding for human tissue factor: Primary structure of the protein and cDNA” Proc. Natl. Acad. Sci. USA 84(15):5148-5152 (1987). |
Stirling, “Warfarin-induced Changes in Procoagulant and Anticoagulant Proteins” Blood Coagulation and Fibrinolysis 6:361-373 (1995). |
Tanaka et al., “Purification of Glycosylated Apoprotein of Tissue Factor from Human Brain and Inhibition of its Procoagulant Activity by a Specific Antibody” Thrombosis Research 40:745-756 (1985). |
Thomas, “Studies on the Intravascular Thromboplastic Effect of Tissue Suspensions in Mice” Bull. Johns Hopkins Hospital 81:26-42 (1947). |
Vehar, “Recombinant DNA Technology and Its Impact on Our Understanding of Factor VIII” Factor VIII/von Willebrand Factor: Biological and Clinical Advances, Proc. Bari Int. Conf., S Wichpig edition, Italy pp. 267-274 (1986). |
Wilcox et al., “Localization of Tissue Factor in the Normal Vessel Wall and in the Atherosclerotic Plaque” Proc. Natl. Acad. Sci. USA 86:2839-2843 (1989). |
Zuniga, M. C. et al., “Expression and Fuction of Transplantation Antigens with Altered or Deleted Cytoplasmic Domains” Cell 34:535-544 (1983). |